There are numerous peptides, some whose discovery dates back to the early 1900s (ie: insulin & oxytocin) and many are FDA‑approved for specific conditions.

Some example include:

• Insulin for metabolic function, assisting with glucose uptake with diabetes
• Tesamorelin for HIV‑related lipodystrophy
• GLP‑1 agonists (semiglutide) for metabolic disease.

In early 2026, US HHS Secretary Robert F Kennedy Jr. signaled that steps would be taken to make 14 peptides, many of which are anecdotally well known, more accessible through lawful compounding channels in the US. 

The FDA’s recent actions suggest that certain peptides may become more accessible in the future, as the agency is reevaluating previous safety designations, removing several peptides from restrictive categories, and initiating formal review processes that could ultimately support their lawful compounding and potential approval.

There are numerous peptides, discovery dating back to 1921 with insulin. May of them them are FDA‑approved for specific conditions (e.g., tesamorelin for HIV‑related lipodystrophy, GLP‑1 agonists for metabolic disease).

Most orthopedic‑focused peptides, however, are still considered experimental, with promising preclinical data and anecdotal evidence, but limited large‑scale clinical trials.

Retatrutide (LY3437943) is currently in Phate 3 trials (Eli Lilly TRIUMPH program) for obesity, and showing exceptional results with up to 28.7% weight loss and other benefits, exceeding the results of semaglutide (Ozempic) and tirzepatide (Mounjaro).

In most jurisdictions, NO formal license is required to purchase research‑grade peptides. However, customers are responsible for ensuring compliance with all local, provincial/state, and federal regulations governing laboratory materials.

Lyophilization is also known as freeze-drying. This process removes water, which:

• Prevents hydrolysis

• Reduces degradation

• Protects peptide structure

• Minimizes microbial growth

This makes the peptide far more stable than in solution.

In general scientific practice, lyophilized (freeze‑dried) peptides are very stable, which is one of the reasons they’re supplied in this form for research. Their shelf life depends on storage conditions, but here’s a simple breakdown researchers typically follow:

General Research Shelf Life for TGM Pure Peptides in lyophilized state:

• At Room Temperature lyophilized peptides are usually stable for weeks to months

• Short‑term storage at room temperature is generally acceptable during shipping or handling

• Refrigerated (2–8°C) extends stability typically to 12–24 months. This is a common storage method for ongoing research use

• Frozen (–20°C or below) can keep peptides stable for several years.

However, once reconstituted (in solution), peptides should be utilized promptly and stored in a dark, refrigerated environment.

Yes. Certificates of Analysis (COAs) and analytical purity documentation are available for all research‑grade peptides and ancillary materials. Current lot documentation is provided directly within each product description, and all vials are clearly labeled with the corresponding lot number that matches the most recent analytical evaluation.

These documents include relevant analytical data such as HPLC purity profiles and mass spectrometry confirmation, along with absence of endotoxin verification, to support verification, safety and reproducibility in research settings.

Yes, bacteriostatic water is a sterile, preservative‑containing solution (0.9% benzyl alcohol) used to reconstitute lyophilized (freeze dried) peptides for laboratory research. It helps maintain sterility, ensures accurate concentrations, and supports consistent research.

Researchers determine how much bacteriostatic water to add by using simple math based on the peptide’s total amount and the concentration they want for their experiment. No medical or usage guidance is involved—this is strictly about lab preparation and measurement.

Lyophilized peptides come as a dry powder with a label showing the total amount (for example: 5 mg or 10 mg). To use that peptide in a laboratory experiment, researchers dissolve it in a specific volume of bacteriostatic water to create a known concentration.

The basic idea is that researchers choose how concentrated they want the solution to be and then add enough bacteriostatic water to reach that concentration

This allows them to measure the peptide accurately during experiments.

Example of the concept (no dosing involved):

If a vial contains 10 mg of peptide and a researcher wants a solution that is 2 mg per mL, they would add 5 mL of bacteriostatic water.

Researchers adjust the volume until the numbers match the concentration they need for their study.

Why this matters in research:

• It creates consistent, repeatable concentrations

• It allows precise measurements for assays and experiments

• It ensures the peptide dissolves fully and evenly

• It supports accurate comparisons between experimental conditions

No. TGM Pure Peptides does not provide dosing, application, or experimental guidance.

All products should be utilized solely under the supervision of a licensed physician and only within appropriate research or clinical‑investigational frameworks.

TGM Pure Peptides does not promote, support, or authorize the use of research‑grade peptides for any therapeutic, medical, or clinical purpose without the explicit direction and oversight of a licensed physician. All products offered on our website are intended strictly for laboratory and research use only.

While our peptides undergo comprehensive third‑party testing to verify identity, purity, and quality, this verification is performed to support safety for research applications and scientific accuracy—not to establish suitability for therapeutic use. Any compound referenced in scientific literature as a potential therapeutic must be handled only within appropriate research settings or under professional medical supervision.

Our commitment to rigorous testing ensures that researchers receive the highest‑quality materials they can rely on, but these standards do not replace medical evaluation, regulatory approval, or clinical guidance.